About Shawn Murphy, Executive Director
Shawn Murphy is the Executive Director of the Thought Leadership & Innovation Foundation (TLI), where she leads national initiatives that advance health equity, data quality, and collaborative innovation across the healthcare ecosystem. With more than two decades of executive leadership experience, Shawn specializes in building strategic partnerships, mobilizing multi-stakeholder networks, and transforming complex ideas into practical, sustainable solutions. She delivers proven technology solutions across patient communities that drive access to data which is then used for research to guide clinical practice and improve patient outcomes.
At TLI, she oversees programs that bridge gaps between healthcare providers, researchers, industry partners, and communities—driving measurable impact in areas such as data modernization, patient advocacy, and population health. Known for her clarity of vision and ability to bring diverse experts together, Shawn is a sought-after advisor on organizational strategy, cross-sector collaboration, and the future of healthcare innovation.
She brings a mission-driven approach to every engagement: empowering organizations to think boldly, execute effectively, and create outcomes that truly matter.
About Thought Leadership & Innovation Foundation
The Thought Leadership & Innovation Foundation (TLI) is a nonprofit organization dedicated to driving innovative thinking and action on global issues relating to health. Working at the nexus of science, technology, and public health, TLI develops collaborative, data-driven approaches that foster transformative change and improve health and well-being for patient communities around the world.
Better Data. Better Care.
Data Will Define the Future: Why the CMS Medicare Advantage Final Rule Matters Beyond Reimbursement
By Shawn Murphy
Executive Director, Thought Leadership & Innovation Foundation and the Limb Loss and Preservation Registry (LLPR)
Healthcare is entering a new era in which reimbursement is increasingly tied to measurable patient outcomes rather than the volume of services delivered. While this transition has been discussed for years, the recent CMS Medicare Advantage Final Rule signals that the shift is no longer theoretical—it is becoming operational policy. I recently co-authored a whitepaper argues that the rule represents a structural change in how healthcare value is defined, measured, and rewarded, creating both new opportunities and new expectations for the orthotics and prosthetics (O&P) community.
For readers of Medical Travel & Digital Health News, however, the implications extend well beyond a single clinical specialty. This is a story about digital transformation, data interoperability, patient-reported outcomes, and the growing role of real-world evidence in healthcare delivery around the world.
Digital health is becoming the infrastructure of value-based care
Healthcare organizations have invested heavily in electronic medical records, artificial intelligence, remote monitoring, and digital patient engagement. Yet technology alone does not create value. What increasingly matters is whether those technologies produce reliable evidence demonstrating improved patient outcomes.
The Medicare Advantage Final Rule reinforces that direction. The emphasis is shifting from administrative process measures toward clinical outcomes and patient experience, while financial incentives become increasingly aligned with measurable quality. As Medicare Advantage plans receive additional funding, they are simultaneously expected to demonstrate greater accountability through outcomes-based performance.
This represents a broader healthcare trend that extends across specialties, geographies, and care settings.
Outcomes data has become a strategic asset
Historically, many specialties—including orthotics and prosthetics—have relied upon expert clinical judgment supported by documentation and professional standards. While those elements remain essential, policymakers and payers increasingly require objective, standardized evidence demonstrating long-term patient benefit.
The whitepaper describes this evolution as a shift from professional discretion toward verification. In the absence of robust specialty-specific outcomes data, healthcare systems frequently default to claims data, utilization patterns, and cost measures as proxies for value.
This has implications well beyond reimbursement because it influences:
- Provider network participation
- Prior authorization policies
- Quality measurement
- Population health management
- Future regulatory development
- Value-based contracting
For digital health innovators, this creates growing demand for technologies capable of collecting standardized longitudinal outcomes data rather than simply digitizing clinical workflows.
Patient-reported outcomes are becoming part of the digital health ecosystem
One of the most important trends highlighted by the Medicare Advantage Final Rule is the increasing importance of patient-centered outcomes.
For individuals living with limb loss or limb preservation, meaningful outcomes extend beyond device delivery. They include:
- Functional mobility
- Independence
- Fall prevention
- Quality of life
- Mental health
- Long-term participation in daily activities
These outcomes increasingly align with the measures that CMS and payers prioritize when evaluating healthcare quality.
Digital health platforms that integrate validated patient-reported outcome measures (PROMs), wearable device data, remote monitoring, and longitudinal follow-up are uniquely positioned to support this evolution.
Registries are evolving into digital infrastructure
Healthcare registries have traditionally been viewed primarily as research tools.
That perception is changing.
Modern clinical registries increasingly function as digital infrastructure supporting:
- Real-world evidence generation
- Benchmarking across organizations
- Population health analytics
- Quality improvement
- Contract negotiations
- Regulatory reporting
The Limb Loss and Preservation Registry was designed to capture standardized longitudinal outcomes across the limb loss, limb difference and limb preservation population using validated assessment tools that measure mobility, function, and quality of life. By aggregating data across providers, registries enable organizations to benchmark performance, demonstrate sustained outcomes, and generate payer-ready evidence.
This reflects a broader transformation occurring across healthcare, where registries increasingly support operational decision-making in addition to research.
Why this matters for medical travel
Medical travel is increasingly driven by demonstrable quality rather than geography alone.
Patients, employers, insurers, and governments are asking similar questions:
- Which providers consistently achieve superior outcomes?
- Which technologies improve long-term function?
- Which rehabilitation programs reduce complications?
- Which centers demonstrate measurable quality?
These questions cannot be answered through marketing alone.
They require trusted, standardized outcomes data.
As cross-border healthcare continues to expand, internationally comparable quality metrics will become increasingly important when evaluating providers and centers of excellence.
Interoperability will become increasingly important
Healthcare organizations are collecting unprecedented amounts of information.
The next challenge is making those data usable.
Digital health leaders will need systems capable of integrating:
- Electronic health records
- Patient-reported outcomes
- Wearable technologies
- Remote patient monitoring
- Clinical registries
- Claims data
Only through interoperability can organizations create the comprehensive longitudinal evidence increasingly expected by regulators, payers, and patients.
Artificial intelligence depends upon high-quality outcomes data
Artificial intelligence continues to reshape healthcare. Yet AI is only as valuable as the data upon which it learns. Predictive analytics, clinical decision support, personalized rehabilitation pathways, and digital therapeutics all depend upon high-quality longitudinal outcomes datasets.
Without standardized clinical outcomes, even sophisticated AI models risk producing incomplete or misleading conclusions. The Medicare Advantage Final Rule indirectly reinforces this reality by increasing the importance of objective measurement rather than subjective assessment.
A global lesson from a U.S. policy change
Although the Medicare Advantage Final Rule applies specifically to the United States, the underlying trend is international.
Health systems worldwide are moving toward:
- Value-based reimbursement
- Evidence-driven policy
- Digital quality measurement
- Population health management
- Patient-centered care
- Real-world evidence
Countries developing national digital health strategies can learn from this transition by investing early in outcomes infrastructure rather than attempting to build it after value-based reimbursement becomes established.
The future belongs to organizations that can prove value
Perhaps the most important message is that outcomes measurement should no longer be viewed as a compliance exercise.
It is becoming a strategic capability.
Organizations that can reliably demonstrate improved patient outcomes will be better positioned to participate in value-based contracting, negotiate with payers, support policy development, and differentiate themselves in increasingly competitive healthcare markets.
Those unable to produce credible evidence risk having their value defined by others through indirect measures such as utilization and cost.
For orthotics and prosthetics, this is a defining moment. But the lesson extends across healthcare: digital transformation is no longer measured by the adoption of technology alone. It is measured by the ability to convert data into trusted evidence that improves patient care and informs healthcare policy.
In the years ahead, the organizations that succeed will not simply be those that collect data—they will be those that transform data into demonstrable value. That is the true promise of digital health, and it is the direction in which healthcare systems around the world are rapidly moving.